Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23,508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical significance of heterogeneity in response to retreatment with epidermal growth factor receptor tyrosine kinase inhibitors in patients with lung cancer acquiring secondary resistance to the drug.
Lee Y, Kim HY, Lee SH, Lim KY, Lee GK, Yun T, Han JY, Kim HT, Lee JS. Lee Y, et al. Among authors: lee sh, lee gk, lee js. Clin Lung Cancer. 2014 Mar;15(2):145-51. doi: 10.1016/j.cllc.2013.11.008. Epub 2013 Nov 14. Clin Lung Cancer. 2014. PMID: 24342626
Complex renal cysts associated with crizotinib treatment.
Schnell P, Bartlett CH, Solomon BJ, Tassell V, Shaw AT, de Pas T, Lee SH, Lee GK, Tanaka K, Tan W, Tang Y, Wilner KD, Safferman A, Han JY. Schnell P, et al. Among authors: lee sh, lee gk. Cancer Med. 2015 Jun;4(6):887-96. doi: 10.1002/cam4.437. Epub 2015 Mar 10. Cancer Med. 2015. PMID: 25756473 Free PMC article.
A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR-Tyrosine Kinase Inhibitors.
Han JY, Lee KH, Kim SW, Min YJ, Cho E, Lee Y, Lee SH, Kim HY, Lee GK, Nam BH, Han H, Jung J, Lee JS. Han JY, et al. Among authors: lee sh, lee gk, lee y, lee js, lee kh. Cancer Res Treat. 2017 Jan;49(1):10-19. doi: 10.4143/crt.2016.058. Epub 2016 May 3. Cancer Res Treat. 2017. PMID: 27188206 Free PMC article. Clinical Trial.
Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer.
Lee Y, Lee KH, Lee GK, Lee SH, Lim KY, Joo J, Go YJ, Lee JS, Han JY. Lee Y, et al. Among authors: lee sh, lee gk, lee js, lee kh. Cancer Res Treat. 2017 Oct;49(4):1001-1011. doi: 10.4143/crt.2016.546. Epub 2017 Jan 13. Cancer Res Treat. 2017. PMID: 28111428 Free PMC article. Clinical Trial.
23,508 results
You have reached the last available page of results. Please see the User Guide for more information.